IGFBP Antibodies

Santa Cruz Biotechnology features a diverse variety of IGFBP monoclonal antibodies for research focused on insulin-like growth factor binding proteins. IGFBP Antibodies are available for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Insulin-like growth factor binding proteins play a crucial role in regulating the availability and activity of insulin-like growth factors, which are essential for cell growth, development, and metabolism. By modulating IGF signaling, IGFBPs are implicated in various physiological processes and have been linked to conditions such as cancer, diabetes, and growth disorders. Understanding IGFBP function is vital for advancing therapeutic strategies and improving patient outcomes. IGFBPs demonstrate distinct expression patterns across different tissues and developmental stages, making them fascinating subjects for developmental biology and disease research. Investigating IGFBP regulation and function can provide valuable insights into cellular signaling pathways and potential therapeutic targets. IGFBP research continues to reveal new mechanisms in growth regulation and metabolic control. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of human health and disease mechanisms.